SCHEMBL516168

SCHEMBL516168

O=CCCC(C=O)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1229361 0.97 HIF1A (0.37)
SCHEMBL9300973 0.83
SCHEMBL1487669 0.79 HIF1A (0.47)
SCHEMBL5694699 0.73 HIF1A (0.39)
SCHEMBL20179681 0.72 HIF1A (0.44)
SCHEMBL14601125 0.69 HIF1A (0.41)
SCHEMBL15926123 0.69
SCHEMBL706040 0.69
SCHEMBL13368624 0.69
SCHEMBL281747 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250268750-A1 PUNCTAL PLUG AND BIOADHESIVES OCULAR THERAPEUTIX INC (US) 2025-08-28 US claimed
CN-116730465-A Method for removing arsenic from high-arsenic contaminated acid 云南驰宏锌锗股份有限公司 2023-09-12 CN claimed
EP-0537218-A1 $g(a)-FORMYLGLUTARALDEHYDES Henkel Kommanditgesellschaft auf Aktien (DE) 1993-04-21 EP claimed
WO-1992000946-A1 α-FORMYLGLUTARALDEHYDES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1992-01-23 WO claimed
EP-4709333-A1 SYSTEMS AND METHODS FOR PROVIDING A VACUUM ASSISTED SECONDARY CLOSURE DEVICE Desvigne, Michael N. (US) 2026-03-18 EP disclosed
US-20250381306-A1 COMPOSITIONS AND METHODS FOR TREATING DIABETIC CARDIOMYOPATHY UNIV UTAH RES FOUND (US) 2025-12-18 US disclosed
WO-2025226604-A1 BRAIN-ASSESSMENT DEVICES AND METHODS OF MAKING AND USING THE SAME ALTOS LABS, INC. (US) 2025-10-30 WO disclosed
EP-4637840-A1 COMPOSITIONS AND METHODS FOR TREATING DIABETIC CARDIOMYOPATHY University of Utah Research Foundation (US) 2025-10-29 EP disclosed
EP-4608466-A1 STIMULI-RESPONSIVE MEDICAL ADHESIVE COMPOSITIONS, ARTICLES, AND METHODS Nuceptive Labs, Inc. (US) 2025-09-03 EP disclosed
US-20250268750-A1 PUNCTAL PLUG AND BIOADHESIVES OCULAR THERAPEUTIX INC (US) 2025-08-28 US disclosed
US-12310890-B2 Punctal plug and bioadhesives OCULAR THERAPEUTIX, INC. (US) 2025-05-27 US disclosed
US-12239758-B2 Adhesive device for biomedical applications and methods of use thereof THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2025-03-04 US disclosed
EP-0733636-A1 Extraction of organic silicon compounds with biological activity from algae EXSYMOL S.A.M. (MC) 1996-09-25 EP disclosed
WO-1994017851-A1 BILAYER COMPOSITE HYDROGELS FOR CORNEAL PROSTHESES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1994-08-18 WO disclosed
WO-1993010773-A1 USE OF NEUTRAL ENDOPEPTIDASE INHIBITORS IN THE TREATMENT OF LEFT VENTRICULAR HYPERTROPHY SCHERING-PLOUGH S.P.A. (IT) 1993-06-10 WO disclosed
EP-0537218-A1 $g(a)-FORMYLGLUTARALDEHYDES Henkel Kommanditgesellschaft auf Aktien (DE) 1993-04-21 EP disclosed
EP-0537218-A1 $g(a)-FORMYLGLUTARALDEHYDES Henkel Kommanditgesellschaft auf Aktien (DE) 1993-04-21 EP disclosed
WO-1992000946-A1 α-FORMYLGLUTARALDEHYDES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1992-01-23 WO disclosed
WO-1992000946-A1 α-FORMYLGLUTARALDEHYDES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1992-01-23 WO disclosed
US-4299726-A Process for preparing whole blood reference controls having long term stability, preconditioning diluent and media therefor COULTER ELECTRONICS, INC. (US) 1981-11-10 US disclosed